市場調查報告書
商品編碼
1510701
歐洲心臟移植市場預測至 2030 年 - 區域分析 - 按手術類型(原位心臟移植和異位心臟移植)、類型(供體活體心臟和人造心臟)和最終用戶(醫院、心臟中心等)Europe Heart Transplant Market Forecast to 2030 - Regional Analysis - by Surgery Type (Orthotopic Heart Transplant and Heterotopic Heart Transplant), Type (Donor Live Heart and Artificial Hearts), and End User (Hospitals, Cardiac Centers, and Others) |
歐洲心臟移植市場預計將從2022年的39.7032億美元成長到2030年的87.8967億美元。
器官移植意識的增強推動歐洲心臟移植市場
在歐洲,提高人們對心臟移植認知的努力包括教育活動、醫療保健提供者和器官採購組織之間的合作、立法舉措以及醫療專業人員和組織的公共宣傳。這些努力旨在讓大眾了解心臟捐贈者的迫切需求,消除擔憂或誤解,並鼓勵個人登記為器官捐贈者。此外,醫療技術和外科技術的進步促進了心臟移植的成功和可行性,進一步凸顯了器官捐贈在拯救生命的重要性。因此,歐洲國家越來越接受和理解心臟移植作為末期心臟衰竭的治療選擇。
歐洲心臟移植市場概況
歐洲心臟移植市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。歐洲在全球心臟移植市場中佔據重要地位,預計 2022 年至 2030 年複合年成長率顯著。導致心臟衰竭的心血管疾病的流行促進了該地區的市場成長。德國因其在醫療保健領域的持續成長和創新方法而成為一個有吸引力的市場。根據聯邦統計局的數據,2021年德國的醫療支出達4,740億美元。隨著年齡的成長,許多器官開始出現故障或功能失調,導致器官移植手術。此外,據世界衛生組織稱,德國約十分之四的死亡是由行為風險因素造成的,包括飲食風險、吸煙、飲酒和體力活動不足。 2021 年,德國近 19% 的成年人患有肥胖症。肥胖會引起各種其他與健康相關的問題。因此,肥胖和超重等公共衛生問題導致的慢性健康障礙可能會刺激德國對器官移植手術的需求。
德國的器官需求與器官捐贈之間存在差距。根據德國器官移植基金會 (DSO) 的數據,2021 年總共捐贈了 2,905 個死後器官,而實際需求為 8,730 個器官。因此,預計未來幾年該國的器官移植手術將大幅成長。
歐洲心臟移植市場收入及 2030 年預測(百萬美元)
歐洲心臟移植市場細分
歐洲心臟移植市場分為手術類型、類型、最終用戶和國家。
根據手術類型,歐洲心臟移植市場分為原位心臟移植和異位心臟移植。到2022年,原位心臟移植領域將在歐洲心臟移植市場中佔據更大佔有率。
從類型來看,歐洲心臟移植市場分為供體活體心臟和人工心臟。 2022年,供體活體心臟部分在歐洲心臟移植市場中佔據較大佔有率。
根據最終用戶,歐洲心臟移植市場分為醫院、心臟中心等。 2022 年,醫院細分市場在歐洲心臟移植市場中佔據最大佔有率。
根據國家/地區,歐洲心臟移植市場分為德國、法國、英國、西班牙、義大利和歐洲其他地區。 2022年,德國將主導歐洲心臟移植市場。
Terumo Corp、Abbott Laboratories、SynCardia Systems LLC、BioVentrix Inc、Berlin Heart GmbH、LivaNova Plc 和 Calon Cardio-Technology Ltd 是歐洲心臟移植市場上的一些領先公司。
表中的內容
The Europe heart transplant market is expected to grow from US$ 3,970.32 million in 2022 to US$ 8,789.67 million by 2030. It is estimated to grow at a CAGR of 10.4% from 2022 to 2030.
Increased Awareness of Organ Transplantation Drives Europe Heart Transplant Market
In Europe, efforts to raise awareness about heart transplantation include educational campaigns, collaboration between healthcare providers and organ procurement organizations, legislative initiatives, and public advocacy from medical professionals and organizations. These efforts aim to inform the public about the critical need for heart donors, address concerns or misconceptions, and encourage individuals to register as organ donors. Additionally, advancements in medical technology and surgical techniques have contributed to the success and viability of heart transplantation, further highlighting the importance of organ donation in saving lives. As a result, there has been an increasing acceptance and understanding of heart transplantation as a treatment option for end-stage heart failure within European countries.
Europe Heart Transplant Market Overview
The Europe heart transplant market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global heart transplant market and is estimated to register a notable CAGR during 2022-2030. The prevalence of cardiovascular diseases, leading to heart failure, contributes to the market growth in the region. Germany is an attractive market due to its consistent growth and innovative approach toward the healthcare sector. According to the Federal Statistical Office, health expenditure in Germany amounted to US$ 474 billion in 2021. The rising geriatric population with the increasing prevalence of chronic disease propels the heart transplant market growth in the country. With the growing age, many organs start to malfunction or become dysfunctional giving rise to organ transplantation procedures. Further, according to the WHO, ~4 in 10 deaths in Germany result from behavioural risk factors, including dietary risks, smoking, alcohol consumption, and low physical activity. In 2021, nearly 19% adults were obese in Germany. Obesity gives rise to various other health-related problems. Thus, public health issues such as obesity and overweight, resulting in chronic health disorders, can fuel the demand for organ transplantation procedures in Germany.
There is a gap between organ demand and organ donations in Germany. According to the German Foundation for Organ Transplantation (DSO), a total of 2,905 organs were donated post-mortem in 2021, in contrast to the need for 8,730 organs. Therefore, organ transplantation procedures are expected to grow in the coming years in the country significantly.
Europe Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Europe Heart Transplant Market Segmentation
The Europe heart transplant market is segmented into surgery type, type, end user, and country.
Based on surgery type, the Europe heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplantation segment held a larger share of the Europe heart transplant market in 2022.
In terms of type, the Europe heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held a larger share of the Europe heart transplant market in 2022. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.
Based on end user, the Europe heart transplant market is segmented into hospitals, cardiac centres, and others. The hospitals segment held the largest share of the Europe heart transplant market in 2022.
Based on country, the Europe heart transplant market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Germany dominated the Europe heart transplant market in 2022.
Terumo Corp, Abbott Laboratories, SynCardia Systems LLC, BioVentrix Inc, Berlin Heart GmbH, LivaNova Plc, and Calon Cardio-Technology Ltd are some of the leading companies operating in the Europe heart transplant market.
Table of Content